Longevity
NAD+ connects an injectable product with a nasal product. The literature search includes nicotinamide adenine dinucleotide and NAD+, while keeping precursor research separate from the catalog’s stated ingredient.
The injection listing uses a monthly quantity; the nasal listing gives a concentration and bottle volume. These fields describe different aspects of a formulation and cannot be compared as if they were the same administered dose.
A paper studying a precursor such as nicotinamide riboside answers a different intervention question from a paper administering NAD+ itself. The atlas preserves the exact paper title and source to make that distinction inspectable.
| Product | Listed formulation | Connected ingredient research |
|---|---|---|
| NAD+ Injection | 1,000 mg per month | NAD+ |
| NAD+ Nasal Spray | 300 mg/ml, 15 ml bottle | NAD+ |
Publication history
The chart counts records mentioning the search terms in their title or abstract. It includes research beyond longevity. Use the period controls to inspect the count.
2026: 2,061 indexed publications. 2026 includes publications dated through October 5. The earlier bars cover longer periods than the annual bars.
| Period | Publications |
|---|---|
| 1900-1959 | 1154 |
| 1960-1969 | 2432 |
| 1970-1979 | 5358 |
| 1980-1989 | 6152 |
| 1990-1999 | 7015 |
| 2000-2009 | 10084 |
| 2010-2014 | 6993 |
| 2015-2019 | 8014 |
| 2020 | 1902 |
| 2021 | 2006 |
| 2022 | 2029 |
| 2023 | 1936 |
| 2024 | 2026 |
| 2025 | 2228 |
| 2026 | 2061 |
Source: Europe PMC’s PubMed-indexed records. Retrieved October 5, 2026. The index’s firstPublicationDate field supplies the dates and chart periods; it can normalize a month-only record to the first day of the month. Dates through October 5 are included. Counts can change as the index adds or corrects records.
TITLE_ABS:(("nicotinamide adenine dinucleotide" OR "NAD+")) AND SRC:MED AND FIRST_PDATE:[1900-01-01 TO 2026-10-05]
The focused search returns 295 publications. It narrows the ingredient query to terms connected with its catalog use. Its displayed records remain a search sample, not a ranking of study quality.
TITLE_ABS:(("nicotinamide adenine dinucleotide" OR "NAD+")) AND TITLE_ABS:((intravenous OR intranasal)) AND SRC:MED AND FIRST_PDATE:[1900-01-01 TO 2026-10-05]
Dated publications
The timeline combines selected references with a sample from the ingredient search. Dates use the index’s firstPublicationDate field; the PubMed record may distinguish an earlier online date from the print date. Written study notes appear alongside the records that have them. Other entries show the indexed bibliography and link to the paper.
research-article · Journal Article
Ciampa EJ, Machado LM, Lee KJ, Clark AJ, Vu KQ, Khan NA, Kispert S, Armstrong S, Li Y, Milne GL, Solmonson A, Karumanchi SA, Parikh SM. Science (New York, N.Y.). PMID 42275500.
This record identifies a publication and its indexed publication types. The full paper contains the study methods, population, formulation and results.
Read the PubMed record · Publisher recordWas the intervention NAD+ itself, a precursor or a laboratory manipulation? Did the source test the injectable or nasal route?
Research data assembled by HealthRX.com from the displayed source records, October 5, 2026. The atlas contains a dated literature search and selected studies; it is not an exhaustive systematic review.